newsfilter
← Latest News
GlobeNewswire·

Albireo Announces Presentation of New Data in Pediatric and Adult Liver Diseases

New analyses of PEDFIC Phase 3 trials show that patients whose pruritus improves on Bylvay® (odevixibat) also experience improvements in sleep, quality of life, serum bile acids and hepatic parameters Long-term data from PEDFIC trials of Bylvay show